Extracorporeal Cytokine hemadsorption therapy

DEVICE2 trials

Sponsors

Institute of Liver and Biliary Sciences, India, Hospital Universitari de Bellvitge

Conditions

Acute Kidney InjuryCardiac Surgery Requiring Cardiopulmonary BypassChronic Kidney Disease(CKD)Kidney Failure, AcuteSeptic Shock

Unknown Phase

Safety and Efficacy of Extracorporeal Cytokine Hemoadsorption in Septic Shock in Critically Ill Cirrhotics

Institute of Liver and Biliary Sciences, IndiaSeptic Shock

Start: 2019-03-01End: 2019-06-30Target: 50Updated: 2019-05-01

SIRAKI 02 Posthoc Analysis.

Active, not recruitingNCT06781294

Hospital Universitari de BellvitgeAcute Kidney Injury, Cardiac Surgery Requiring Cardiopulmonary Bypass, Chronic Kidney Disease(CKD) +1

Start: 2024-10-01End: 2027-03-01Updated: 2026-08-31